Prothena Corp Public (PRTA) Interest & Investment Income (2012 - 2016)
Prothena Corp Public (PRTA) posted quarterly Interest & Investment Income of $277000.0 for Q1 2016, up 965.38% year-over-year from $26000.0 in Q2 2015, and up 246.25% quarter-over-quarter from $80000.0 in Q4 2015.
Powered by 
Analysis
Prothena Corp Public (PRTA) Interest & Investment Income (2012 - 2016) Analysis & Trends
Prothena Corp Public's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $277000.0 for Q1 2016.
- In Q1 2016, Interest & Investment Income rose 965.38% year-over-year to $277000.0; the TTM figure through Mar 2016 stood at $447000.0 (up 419.77% YoY), while the FY2015 annual figure was $196000.0, up 148.1% from the prior year.
- Interest & Investment Income for Q1 2016 stood at $277000.0, up from $80000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $277000.0 in Q1 2016, with the low at $5000.0 in Q4 2012.
- The 5-year median for Interest & Investment Income is $21500.0 (2013), against an average of $44857.1.
- The sharpest annual moves came in 2014 and 2016: Interest & Investment Income dropped 13.64% in 2014, then soared 965.38% in 2016.
- Prothena Corp Public's Interest & Investment Income stood at $5000.0 in 2012, then soared by 320.0% to $21000.0 in 2013, then advanced by 19.05% to $25000.0 in 2014, then jumped by 220.0% to $80000.0 in 2015, then jumped by 246.25% to $277000.0 in 2016.
- Business Quant data shows PRTA's Interest & Investment Income at $277000.0 in Q1 2016, $80000.0 in Q4 2015, and $50000.0 in Q3 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Prothena Corp Public | 507.63 Mn | 219.43 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | 277,000.00 |
| Dec 31, 2015 | 80,000.00 |
| Sep 30, 2015 | 50,000.00 |
| Jun 30, 2015 | 40,000.00 |
| Mar 31, 2015 | 26,000.00 |
| Dec 31, 2014 | 25,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Jun 30, 2014 | 16,000.00 |
| Mar 31, 2014 | 19,000.00 |
| Dec 31, 2013 | 21,000.00 |
| Sep 30, 2013 | 14,000.00 |
| Jun 30, 2013 | 14,000.00 |
| Mar 31, 2013 | 22,000.00 |
| Dec 31, 2012 | 5,000.00 |